Ceiling respiratory depression by dezocine.

Area of Science:

• Pharmacology
• Respiratory Physiology
• Pain Management

Background:

• Agonist-antagonist analgesics offer potential advantages over traditional opioids.
• Understanding the respiratory effects of dezocine is crucial for clinical application.
• Morphine serves as a benchmark for comparing analgesic and respiratory depressant effects.

Purpose of the Study:

• To compare the respiratory depressant effects of dezocine and morphine in healthy subjects.
• To investigate the dose-response relationship and duration of dezocine's respiratory effects.
• To assess the efficacy of naloxone in antagonizing dezocine-induced respiratory depression.

Main Methods:

• Six healthy subjects received equianalgesic intravenous doses of dezocine and morphine.
• Respiratory response to carbon dioxide (CO2) breathing was measured.
• Naloxone was administered to evaluate antagonism of respiratory depression.

Main Results:

• Dezocine caused similar respiratory depression to morphine, but with a faster onset and higher peak effect.
• Respiratory depression was dose-related up to 30 mg/70 kg, with no further increase at 40 mg/70 kg.
• Naloxone rapidly antagonized dezocine's effects, but the antagonism was short-lived (less than 1 hour).

Conclusions:

• Dezocine exhibits a ceiling effect for respiratory depression, similar to other agonist-antagonist analgesics like nalorphine and nalbuphine.
• While effective, dezocine may produce less pleasant subjective effects and potential psychotomimetic sensations at higher doses.
• The rapid but transient antagonism by naloxone highlights the complex interaction and warrants further investigation into agonist-antagonist analgesic characteristics.